您的位置: 首页 > 农业专利 > 详情页

PYRIDINE DERIVATIVES AS VEGFR-2 RECEPTOR AND PROTEIN TYROSINE KINASE INHIBITORS
专利权人:
LEO PHARMA A/S
发明人:
FELDING, JAKOB,LIANG, XIFU,HORNEMAN, ANNE MARIE,POULSEN, TINA, DAHLERUP,LARSEN, JENS, CHRISTIAN, HOJLAND
申请号:
NZ59182009
公开号:
NZ591820A
申请日:
2009.08.27
申请国别(地区):
NZ
年份:
2012
代理人:
摘要:
591820 Disclosed are amides and thioamides of formula I. Specific examples of compounds of formula I include: (4-{ [2-(3,3-Dimethyl-butylcarbamoyl)-phenylamino]-methyl} -pyridin-2-yl)carbamic acid methyl ester, 2-[(2-Acetylamino-pyridin-4-ylmethyl)-amino]-N-(3-ethyI-pentyl)-benzamide, Furan-2-carboxylic acid (4-{ [2-(4-methyl-pentylcarbamoyl)-phenylamino]-methyl} -pyridin-2-yl)-amide, and Furan-2-carboxylic acid (4-{ [2-(3-ethyl-pentylcarbamoyl)-phenylamino]-methyl} -pyridin-2-yl)-amide. Compounds of formula I exhibit a high receptor tyrosine kinase inhibitory activity on the receptor VEGFR-2, also referred to as the KDR receptor. The compounds inhibit angiogenesis, which is beneficial for treating diseases such as atherosclerosis, inflammatory conditions such as dermatitis, psoriasis, rosacea and rheumatoid arthritis, eye diseases such as diabetic retinopathy and macular degeneration, and cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充